PFKFB4调控血管正常化和免疫微环境重编程抑制三阴性乳腺癌发展的机制研究

负责人:罗娜

依托单位:南开大学

批准年份:2021

前往基金查询
评论区 (1)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2126302, encodeId=3cfe21263022a, content=<a href='/topic/show?id=e9fb141220d' target=_blank style='color:#2F92EE;'>#PFKFB4#</a>调控<a href='/topic/show?id=4f08105889cf' target=_blank style='color:#2F92EE;'>#血管正常化#</a>和<a href='/topic/show?id=029e2901e8e' target=_blank style='color:#2F92EE;'>#免疫微环境#</a>重编程抑制<a href='/topic/show?id=33771982175' target=_blank style='color:#2F92EE;'>#三阴性乳腺癌#</a>发展的机制研究, beContent=null, objectType=nsfc, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14122, encryptionId=e9fb141220d, topicName=PFKFB4), TopicDto(id=105889, encryptionId=4f08105889cf, topicName=血管正常化), TopicDto(id=29017, encryptionId=029e2901e8e, topicName=免疫微环境), TopicDto(id=19821, encryptionId=33771982175, topicName=三阴性乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Sun Apr 16 16:29:42 CST 2023, time=2023-04-16, status=1, ipAttribution=香港)]
    2023-04-16 侠胆医心 来自香港

    #PFKFB4#调控#血管正常化##免疫微环境#重编程抑制#三阴性乳腺癌#发展的机制研究

    0